Daniel Öhman appointed new CEO of Carasent

The board of directors of Carasent ASA has today appointed Daniel Öhman as the Company’s new Chief Executive Officer (CEO). He will succeed Dennis Höjer, who has been CEO since December 2020. Öhman will start no later than 2 January 2023.

During Öhman’s leadership, GHP Specialty Care’s valuation increased from 370 MSEK to 2 450 MSEK, turnover doubled, and EBITDA increased from 50 MSEK to 200 MSEK. Öhman was also instrumental in developing GHP Solutions, a business area within which healthcare is sold as a subscription service and continuously refined using a uniquely comprehensive data layer.

Daniel Öhman, CEO of Carasent

– We are pleased to welcome Daniel Öhman to Carasent. He has done an impressive job growing GHP Speciality Care over the last nine years. His industry knowledge and experience in both organic and international growth are very much aligned with Carasent’s ambitions going forward. We are confident that this change in management will benefit our customers, employees, and investors, says Johan Lindqvist, Chairman of the Board.

Daniel Öhman has been with GHP Speciality Care in various positions since 2006 and has managed the company during heavy expansion, both financially and geographically. He has experience growing business in the UK, the Czech Republic, the Middle East, Denmark and Norway.

– I look forward to joining Carasent and joining this exciting company. As a customer, I know
them well. Carasent is not the largest provider, but their platform is the best. The challenge is now to grow and to become number one, says Daniel Öhman.

The Board extends its gratitude to Dennis Höjer, who will continue as acting CEO until Daniel Öhman assumes the position.

About the Company:
Carasent ASA was founded in 2012 with a mission to drive efficiency and quality in the world of care. In 2018, the Company acquired Evimeria EMR AB, a Swedish company that develops and delivers Webdoc, a cloud-based medical practice management system. Since then, three acquisitions have been completed, adding new products to the portfolio and new customer segments to the customer list. Carasent’s core offerings are cloud-based EHR solutions and a broad ecosystem of platform services, including solutions for patient communication and business intelligence. 

For further information, please contact:
Svein Martin Bjørnstad, CFO Carasent ASA, phone: +47 979 69 493 
Daniel Öhman, phone: +46 708 553707

More news